Topical sucralfate in the management of peristomal skin disease: An open study

Clinical and Experimental Dermatology

Volumn 25, Issue 8, 2000, Pages 584-588

  Lyon, Calum C ^a,b   Stapleton, Mark ^a,b   Smith, Amanda J ^a,b   Griffiths, Christopher E M ^a   Beck, Michael H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; SUCRALFATE;

ADULT; AGED; ARTICLE; CELL PROTECTION; CLINICAL ARTICLE; COLOSTOMY; DRUG EFFICACY; EPITHELIZATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PYODERMA GANGRENOSUM; RISK BENEFIT ANALYSIS; SKIN DISEASE; STOMA; WOUND HEALING;

ABDOMEN; ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN DISEASES; STOMAS; SUCRALFATE; TREATMENT OUTCOME;

EID: 0034493699     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2000.00711.x     Document Type: Article

References (14)

1. Dermatological problems in Stoma patients
2. Dermatologic complications in colostomy and ileostomy patients
3. Peristomal dermatoses; a novel indication for topical steroid lotions
4. Mucosal coating agents and other non-sentisecretory agents
5. Pathways of gastrointestinal protection and repair: Mechanisms of action of sucralfate
6. Heparin affinity for cationic and ionic capillary endothelial growth factors: Analysis of hypothalamus-derived growth factors and fibroblast growth factors
7. Duodenal ulcer
8. Topical sucralfate: Effective therapy for the management of resistant peristomal and perineal excoriation
9. Parastomal Pyoderma Gangrenosum: Clinical features and Mangement
10. Development and characteristics of sucralfate
11. Antibacterial activity of sucralfate in human gastric juice
12. Skin protection by sucralfate cream during electron beam therapy
13. A comparison of sucralfate and prednisolone enemas in the treatment of active distal ulcerative colitis
14. Heparin, cell adhesion and pathogenesis of inflammatory bowel disease